Last reviewed · How we verify

NCT04333745

Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers

Active, enrolled NA Last updated 9 March 2026
What this trial tests

NA trial testing Controlled Diet in Kidney Stone in 22 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 September 2021
Primary endpoint
1 August 2026
1 December 2026

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment22
Start date1 September 2021
Primary completion1 August 2026
Estimated completion1 December 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 19 to 75, any sex, with Kidney Stone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goals of this study are to determine the contribution of dietary oxalate absorption, renal oxalate handling, and endogenous oxalate synthesis to urinary oxalate excretion in normal Body Mass Index (BMI) and obese calcium oxalate kidney stone formers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Controlled Diet

Trials testing the same drug.

Other recruiting trials for Kidney Stone

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04333745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing